Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
44
BNTC Quote, Financials, Valuation and Earnings
Last price:
$10.73
Seasonality move
:
27.63%
Day range:
$10.50 - $10.95
52-week range:
$9.80 - $17.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.97x
Volume:
132.2K
Avg. volume:
135.4K
1-year change:
-5.13%
Market cap:
$368.3M
Revenue:
--
EPS (TTM):
-$0.93
Benitec Biopharma, Inc. Number of Institutional Trades
Benitec Biopharma, Inc. Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$35.9M
(Last 6 Months)
Current Institutional Ownership Percentage
78.28%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$5.7M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Benitec Biopharma, Inc. Institutional Ownership
-
What Percentage Of BNTC Is Owned by Institutions?
78.28% of BNTC is owned by institutions.
-
How Many Institutions Own BNTC Shares?
Benitec Biopharma, Inc. stock is owned by 105 institutional shareholders at this time.
-
Have Institutions Been Buying BNTC Stock?
Yes, institutions have bought 0 shares of BNTC in the last quarter.
-
Have Institutions Been Selling BNTC Stock?
Yes, institutions have sold 0 shares of BNTC over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
ACLX alert for Feb 24
Arcellx, Inc. [ACLX] is up 77.43% over the past day.
Buy
65
RNG alert for Feb 24
RingCentral, Inc. [RNG] is down 12.48% over the past day.
Buy
69
SNSE alert for Feb 24
Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.
